(S)-2-((R)-2-{[(3S,6S,12R)-12-(3-Guanidino-propyl)-5,11,14-trioxo-20-oxa-4,10,13-triaza-tricyclo[19.2.2.0*6,10*]pentacosa-1(24),21(25),22-triene-3-carbonyl]-amino}-3-methyl-pentanoylamino)-4-methyl-pentanoic acid

ID: ALA1790704

Chembl Id: CHEMBL1790704

PubChem CID: 56665343

Max Phase: Preclinical

Molecular Formula: C38H60N8O8

Molecular Weight: 756.95

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CC[C@@H](C)[C@@H](NC(=O)[C@@H]1Cc2ccc(cc2)OCCCCCC(=O)N[C@H](CCCN=C(N)N)C(=O)N2CCC[C@H]2C(=O)N1)C(=O)N[C@@H](CC(C)C)C(=O)O

Standard InChI:  InChI=1S/C38H60N8O8/c1-5-24(4)32(35(50)44-29(37(52)53)21-23(2)3)45-33(48)28-22-25-14-16-26(17-15-25)54-20-8-6-7-13-31(47)42-27(11-9-18-41-38(39)40)36(51)46-19-10-12-30(46)34(49)43-28/h14-17,23-24,27-30,32H,5-13,18-22H2,1-4H3,(H,42,47)(H,43,49)(H,44,50)(H,45,48)(H,52,53)(H4,39,40,41)/t24-,27-,28+,29+,30+,32-/m1/s1

Standard InChI Key:  LTVAGLBMDPWQGE-PGHZORDASA-N

Associated Targets(Human)

NTSR2 Tchem Neurotensin receptor (16 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 756.95Molecular Weight (Monoisotopic): 756.4534AlogP: 1.34#Rotatable Bonds: 13
Polar Surface Area: 247.64Molecular Species: ZWITTERIONHBA: 8HBD: 7
#RO5 Violations: 2HBA (Lipinski): 16HBD (Lipinski): 9#RO5 Violations (Lipinski): 3
CX Acidic pKa: 4.11CX Basic pKa: 10.83CX LogP: -0.04CX LogD: -0.04
Aromatic Rings: 1Heavy Atoms: 54QED Weighted: 0.09Np Likeness Score: 0.78

References

1. Lundquist JT, Dix TA..  (1999)  Preparation and receptor binding affinities of cyclic C-terminal neurotensin (8-13) and (9-13) analogues.,  (17): [PMID:10498212] [10.1016/s0960-894x(99)00420-5]

Source